ENYO PHARMA Investigative site 0423 — Savannah, Georgia

ENYO PHARMA Investigative site 0423 is a clinical research site located in Savannah, Georgia, United States 31406.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

ENYO PHARMA Investigative site 0423 has participated in 1 clinical trials.

Therapeutic areas: Non-alcoholic Steatohepatitis.

Sponsors: Enyo Pharma.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ENYO PHARMA Investigative site 0423?

ENYO PHARMA Investigative site 0423 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ENYO PHARMA Investigative site 0423 conducted?

ENYO PHARMA Investigative site 0423 has 1 clinical trials on record. Their work covers Non-alcoholic Steatohepatitis.

Is ENYO PHARMA Investigative site 0423 accredited by Crixeo Health?

ENYO PHARMA Investigative site 0423 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about ENYO PHARMA Investigative site 0423?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.